{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:25:35Z","timestamp":1766503535019,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","interventional.theclinics.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.iccl.2024.07.002","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:35:11Z","timestamp":1722857711000},"page":"543-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antithrombotic Therapy in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion"],"prefix":"10.1016","volume":"13","author":[{"given":"Roberto","family":"Galea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccl.2024.07.002_bib1","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.4244\/EIJ-D-19-00128","article-title":"Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study","volume":"15","author":"Cresti","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2024.07.002_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2024.07.002_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2023.05.022","article-title":"Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation","volume":"264","author":"Kar","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2024.07.002_bib4","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2024.07.002_bib5","first-page":"109","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Writing Committee","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.002_bib6","doi-asserted-by":"crossref","first-page":"euad067","DOI":"10.1093\/europace\/euad067","article-title":"Leap or lag: left atrial appendage closure and guidelines","volume":"25","author":"Camm","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.iccl.2024.07.002_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2024.07.002_bib8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2023.02.027","article-title":"Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success: A Swiss-Apero Trial Subanalysis","volume":"16","author":"Galea","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jcin.2021.05.042","article-title":"Impact of echocardiographic guidance on safety and efficacy of left atrial appendage closure: an observational study","volume":"14","author":"Galea","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib10","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.iccl.2024.07.002_bib11","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s10554-021-02206-2","article-title":"Device neo-endothelialization after left atrial appendage closure: the role of cardiac computed tomography angiography","volume":"37","author":"Galea","year":"2021","journal-title":"Int J Cardiovasc Imag"},{"key":"10.1016\/j.iccl.2024.07.002_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2006.02.005","article-title":"The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial","volume":"151","author":"Fountain","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2024.07.002_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ahj.2018.12.010","article-title":"Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial)","volume":"211","author":"Lakkireddy","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.iccl.2024.07.002_bib14","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.4244\/EIJ-D-22-00627","article-title":"Left atrial appendage occlusion","volume":"18","author":"Holmes","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2024.07.002_bib15","doi-asserted-by":"crossref","first-page":"e2138","DOI":"10.4244\/EIJ-D-17-00901","article-title":"Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices","volume":"13","author":"Weise","year":"2018","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.iccl.2024.07.002_bib16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12265-020-10095-4","article-title":"Design and\u00a0Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure","volume":"14","author":"Galea","year":"2021","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.iccl.2024.07.002_bib17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2024.07.002_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.21037\/atm-20-4755","article-title":"Clinical outcomes of bivalirudin versus heparin in atrial fibrillation patients undergoing percutaneous left atrial appendage occlusion","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.iccl.2024.07.002_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.31083\/j.rcm2412343","article-title":"Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions","volume":"24","author":"Galea","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.iccl.2024.07.002_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ccd.22536","article-title":"Transcatheter occlusion of the left atrial appendage--experimental testing of a new Amplatzer device","volume":"76","author":"Bass","year":"2010","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1540-8167.2012.02360.x","article-title":"Incomplete endothelialization of left atrial appendage occlusion device 10 months after implantation","volume":"23","author":"Massarenti","year":"2012","journal-title":"J\u00a0Cardiovascular Electrophysiol"},{"key":"10.1016\/j.iccl.2024.07.002_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jcin.2010.04.017","article-title":"Left atrial appendage obliteration: mechanisms of healing and intracardiac integration","volume":"3","author":"Schwartz","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2024.07.002_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2024.07.002_bib25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2024.07.002_bib26","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2024.07.002_bib27","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.iccl.2024.07.002_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial","volume":"145","author":"Galea","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.iccl.2024.07.002_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.123.067599","article-title":"One-year outcomes after amulet or watchman device for percutaneous left atrial appendage closure: a pre-specified analysis of the SWISS-APERO randomized clinical trial","volume":"149","author":"Galea","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2024.07.002_bib30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2024.07.002_bib31","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.iccl.2024.07.002_bib32","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jcin.2023.06.022","article-title":"3-Year Outcomes from the AmplatzerTMAmuletTMLeft Atrial Appendage OccluderRandomized Controlled Trial (Amulet IDE)","volume":"16","author":"Lakkireddy","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","article-title":"Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN","volume":"12","author":"Sondergaard","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2022.02.009","article-title":"Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib35","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2024.07.002_bib36","doi-asserted-by":"crossref","first-page":"e008481","DOI":"10.1161\/CIRCINTERVENTIONS.119.008481","article-title":"Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study","volume":"13","author":"Duthoit","year":"2020","journal-title":"Circulation Cardiovascular interventions"},{"issue":"9","key":"10.1016\/j.iccl.2024.07.002_bib37","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/europace\/euac021","article-title":"Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study","volume":"24","author":"Galea","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.iccl.2024.07.002_bib38","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4244\/EIJ-D-17-00493","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical\/echocardiographic data from a global prospective observational study","volume":"13","author":"Landmesser","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2024.07.002_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4244\/EIJV15I8A119","article-title":"Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure. What we see depends on where we are looking from and what we are looking for","volume":"15","author":"Holmes","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2024.07.002_bib40","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.iccl.2024.07.002_bib41","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.4244\/EIJ-D-17-00672","article-title":"Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study","volume":"13","author":"Bergmann","year":"2018","journal-title":"EuroIntervention"},{"issue":"30","key":"10.1016\/j.iccl.2024.07.002_bib42","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2024.07.002_bib43","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2024.07.002_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-17-00201","article-title":"Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study","volume":"13","author":"Nielsen-Kudsk","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2024.07.002_bib45","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2024.07.002_bib46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.hrthm.2020.01.028","article-title":"Percutaneous left atrial appendage closure in patients with prior intracranial bleeding and thromboembolism","volume":"17","author":"Pouru","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.iccl.2024.07.002_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2020.08.013","article-title":"Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion","volume":"134","author":"Patti","year":"2020","journal-title":"Am J Cardiol"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:55:38Z","timestamp":1725836138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745824000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2211745824000671"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.002","relation":{},"ISSN":["2211-7458"],"issn-type":[{"type":"print","value":"2211-7458"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2024.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}